Trials / Completed
CompletedNCT01138943
Chlorhexidine Mouthrinses and Plaque Control
Chlorhexidine Alcohol Base Mouthrinse Versus Chlorhexidine Formaldehyde Base Mouthrinse Efficacy on Plaque Control: Double Blind, Randomized Clinical Trials
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hôpital Militaire De Rabat · Academic / Other
- Sex
- All
- Age
- 20 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study was to compare antiplaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F).
Detailed description
Chlorhexidine (CLX) mouthrinse has been the gold standard as antiplaque solution.However, if its efficiency seems to be preserved even if the chlorhexidine concentration is bellow 0.10%, the formulation of the final product may affect the effectiveness. Thus, it can be concluded from this study that 0.12% CLX alcohol base mouthrinse is significantly more effective in inhibiting plaque than the diluted 0.1% CLX non-alcohol base containing formaldehyde mouthrinse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Synthodont | 15 ml, tree times/day for 07 days Arm: Chlorhexidine alcohol-base mouthrinse |
| DRUG | Soludent | 15ml of 01% Chlorhexidine non alcohol-based, 3 times a day for 7 days Arm: Experimental: non alcohol chlorhexidine mouthrinse |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2007-03-01
- Completion
- 2007-04-01
- First posted
- 2010-06-08
- Last updated
- 2011-05-16
Locations
1 site across 1 country: Morocco
Source: ClinicalTrials.gov record NCT01138943. Inclusion in this directory is not an endorsement.